ArticleNature biotechnology2014
Nature's contribution to today's pharmacopeia.
Abstract readLetter
In one paragraph
Article in Nature biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- The integration of machine learning into traditional Chinese medicine.Journal of pharmaceutical analysis · 2025Review
- Identification of potential MMP-8 inhibitors through virtual screening of natural product databases.In silico pharmacology · 2025Article
- EMNPD: a comprehensive endophytic microorganism natural products database for prompt the discovery of new bioactive substances.Journal of cheminformatics · 2023Article
- Macrocycles in Drug Discovery─Learning from the Past for the Future.Journal of medicinal chemistry · 2023Review
- NPASS database update 2023: quantitative natural product activity and species source database for biomedical research.Nucleic acids research · 2023Article
- Exploring Natural Product Activity and Species Source Candidates for Hunting ABCB1 Transporter Inhibitors: An In Silico Drug Discovery Study.Molecules (Basel, Switzerland) · 2022Article
- Actinobacteria from Antarctica as a source for anticancer discovery.Scientific reports · 2020Article
- Closing the Gap Between Therapeutic Use and Mode of Action in Remedial Herbs.Frontiers in pharmacology · 2019Article
- NPASS: natural product activity and species source database for natural product research, discovery and tool development.Nucleic acids research · 2018Article
- Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target.Frontiers in pharmacology · 2018Article
- A Review of the Phytochemistry and Pharmacology ofFrontiers in pharmacology · 2018Article
- Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review.Frontiers in pharmacology · 2017Review
- CancerHSP: anticancer herbs database of systems pharmacology.Scientific reports · 2015Article
- Clustered distribution of natural product leads of drugs in the chemical space as influenced by the privileged target-sites.Scientific reports · 2015Article
- (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels.Angewandte Chemie (International ed. in English) · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Lin Tao1] Shenzhen Kivita Innovative Drug Discovery Institute, Pharmaceutical Sciences, School of Medicine, Tsinghua University, Beijing, P.R. China, and the Ministry-Province Jointly Constructed Base for State Key Lab-Shenzhen Key Laboratory of Chemical Biology, the Graduate School at Shenzhen, Tsinghua University, Shenzhen, P.R. China. [2] Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, Singapore. [3] NUS Graduate School for Integrative Sciences and Engineering, Singapore.
Feng ZhuBioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, Singapore.
Chu Qin1] Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, Singapore. [2] NUS Graduate School for Integrative Sciences and Engineering, Singapore.
Cheng ZhangBioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, Singapore.
Feng XuState Key Laboratory of Medicinal Chemistry &Biology, Tianjin International Joint Academy of Biotechnology &Medicine, Tianjin, China.
Chun Yan Tan1] Shenzhen Kivita Innovative Drug Discovery Institute, Pharmaceutical Sciences, School of Medicine, Tsinghua University, Beijing, P.R. China, and the Ministry-Province Jointly Constructed Base for State Key Lab-Shenzhen Key Laboratory of Chemical Biology, the Graduate School at Shenzhen, Tsinghua University, Shenzhen, P.R. China. [2] Shenzhen Kivita Innovative Drug Discovery Institute, Pharmaceutical Sciences, School of Medicine, Tsinghua University, Beijing, P.R. China, and the Ministry-Province Jointly Constructed Base for State Key Lab-Shenzhen Key Laboratory of Chemical Biology, the Graduate School at Shenzhen, Tsinghua University, Shenzhen, P.R. China.
Yu Yang JiangShenzhen Kivita Innovative Drug Discovery Institute, Pharmaceutical Sciences, School of Medicine, Tsinghua University, Beijing, P.R. China, and the Ministry-Province Jointly Constructed Base for State Key Lab-Shenzhen Key Laboratory of Chemical Biology, the Graduate School at Shenzhen, Tsinghua University, Shenzhen, P.R. China.
Yu Zong Chen1] Shenzhen Kivita Innovative Drug Discovery Institute, Pharmaceutical Sciences, School of Medicine, Tsinghua University, Beijing, P.R. China, and the Ministry-Province Jointly Constructed Base for State Key Lab-Shenzhen Key Laboratory of Chemical Biology, the Graduate School at Shenzhen, Tsinghua University, Shenzhen, P.R. China. [2] Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, Singapore. [3] NUS Graduate School for Integrative Sciences and Engineering, Singapore.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Biological ProductsDrug IndustryHumansUnited StatesUnited States Food and Drug AdministrationBiological Products
Identifiers
PMID
25299914What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.